NCT01345591

Brief Summary

Injuries resulting in facial trauma are common, and can have devastating consequences on your quality of life. While the facial bones can often be reconstructed, physicians strive to find better ways to accurately restore injured facial features. In this clinical trial funded by the Department of Defense, the investigators are evaluating how effectively fat grafting can restore facial features, and how the filling effect of the fat graft lasts over time in participants with visible facial injuries. All procedures for this research study will be performed at the University of Pittsburgh Medical Center.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2009

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

April 14, 2011

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 2, 2011

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

May 12, 2017

Completed
Last Updated

July 11, 2017

Status Verified

June 1, 2017

Enrollment Period

4.9 years

First QC Date

April 14, 2011

Results QC Date

November 14, 2016

Last Update Submit

June 9, 2017

Conditions

Keywords

BTICraniomaxillofacial (CMF) Battle-injured (BI)Facial TraumaFat GraftsAutogenous Fat Transfers (AFT)Wounded warriors

Outcome Measures

Primary Outcomes (1)

  • Volume

    fat graft volume

    3 months and 9 months post op.

Secondary Outcomes (1)

  • SWAP, COPE and CSQ-8

    as assessed at baseline, 7-21 days, 3 months and 9 months post op.

Study Arms (1)

Fat Grafting

EXPERIMENTAL

Twenty (20) subjects who have had severe facial trauma, 18 years of age and older enrolled to clinical trial will receive Fat grafting intervention procedure

Procedure: Fat Grafting

Interventions

Fat GraftingPROCEDURE
Fat Grafting

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older and able to provide informed consent
  • Have suffered injury resulting in craniofacial volume defects which could be treated with a graft volume of between 5 and 150 cc of lipoaspirate
  • Be at least 3 months post-injury or post-surgery (from trauma procedures) so that acute edema is resolved
  • Volume defects are covered by intact skin and do not communicate with oral cavity or sinuses
  • The three dimensional geometry of the volume defects would allow for treatment with lipoaspirate injection that in a manner that at least two distinct treated areas could be discerned on gross examination and radiographically (e.g. treated regions are on opposite sides of the face, on lower face versus upper face, or separated by a bony landmark such as zygoma. This would include the ability to treat an uninjured contralateral region with lipoaspirate in order to obtain symmetry.
  • Willing and able to comply with follow up examinations, including radiographic studies -

You may not qualify if:

  • Age less than 18 years
  • Inability to provide informed consent
  • Craniofacial defects intended for treatment have open wounds or communicate with oral cavity or sinus (note: presence of such a defect in the setting of another defect(s) that meets treatment criteria will not exclude the patient from participating).
  • Active infection anywhere in the body
  • Diagnosed with cancer within the last 12 months and /or presently receiving chemotherapy or radiation treatment
  • Known coagulopathy
  • Pregnancy -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh

Pittsburgh, Pennsylvania, 15213, United States

Location

Related Publications (3)

  • Coleman SR. Structural fat grafting: more than a permanent filler. Plast Reconstr Surg. 2006 Sep;118(3 Suppl):108S-120S. doi: 10.1097/01.prs.0000234610.81672.e7.

    PMID: 16936550BACKGROUND
  • Burnouf M, Buffet M, Schwarzinger M, Roman P, Bui P, Prevot M, Deleuze J, Morini JP, Franck N, Gorin I, Dupin N. Evaluation of Coleman lipostructure for treatment of facial lipoatrophy in patients with human immunodeficiency virus and parameters associated with the efficiency of this technique. Arch Dermatol. 2005 Oct;141(10):1220-4. doi: 10.1001/archderm.141.10.1220.

    PMID: 16230558BACKGROUND
  • Kaufman MR, Bradley JP, Dickinson B, Heller JB, Wasson K, O'Hara C, Huang C, Gabbay J, Ghadjar K, Miller TA. Autologous fat transfer national consensus survey: trends in techniques for harvest, preparation, and application, and perception of short- and long-term results. Plast Reconstr Surg. 2007 Jan;119(1):323-331. doi: 10.1097/01.prs.0000244903.51440.8c.

    PMID: 17255689BACKGROUND

MeSH Terms

Conditions

Facial Injuries

Condition Hierarchy (Ancestors)

Craniocerebral TraumaTrauma, Nervous SystemNervous System DiseasesWounds and Injuries

Results Point of Contact

Title
J. Peter Rubin
Organization
University of Pittsburgh

Study Officials

  • Joseph P Rubin, MD

    Associate Professor of Plastic Surgery at the University of Pittsburgh, Faculty appointment-McGowan Institute of Regenerative Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 14, 2011

First Posted

May 2, 2011

Study Start

September 1, 2009

Primary Completion

August 1, 2014

Study Completion

August 1, 2014

Last Updated

July 11, 2017

Results First Posted

May 12, 2017

Record last verified: 2017-06

Data Sharing

IPD Sharing
Will share

It is the Principal Investigator's intention to make stored samples and subject information de-identified available to secondary investigators (investigators not listed on the front page of this consent document) after all research study testing has been completed. These stored samples and associated subject information will not include subject identifiers.

Locations